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of the patient’s choice.
After the operation, the post opt was very stormy
Patient refused for further operation
One clip managed to do the track and can reduced the MR
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[CLINICAL INFORMATION]
Patient initials or identiﬁer number. KSY
Relevant clinical history and physical exam. KSY was a 74-year-old
woman with history of mitral valve replacement done 24 years ago for
her chronic rheumatic heart disease. The mitral valve prosthesis was a
29mm single tilting disc mechanical heart valve from Sorin. She also
has history of atrial ﬁbrillation and cerebellar hemorrhage.
She was admitted for heart failure symptoms lately, and was found
to have symptomatic aortic stenosis from subsequent investigations.
Transfemoral transcatheter aortic valve implantation (TAVI) was
planned.Relevant test results prior to catheterization. Transthoracic echocardiogram
(TTE) showedsevereaortic stenosiswithpeakandmean transaorticgradient
to be68mmHgand 38mmHg respectively. The aortic valve areawas 0.67 sq
cm by continuity equation. Themitral prosthesis was functionally well.
Preprocedural screening Computed tomography (CT) of aorta was done
for aortic and peripheral vessels sizing. Aortic annulus dimensions were
26.5mm x 20.0mm, area was 445.8 sq mm, and perimeter was 76.39mm.
S466 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5Relevant catheterization ﬁndings. Pre-TAVI coronary angiogram showed
normal coronary arteries.
Angiogram and measurements of aortic root, descending aorta and
the left femoral artery are shown in the attached images.[INTERVENTIONAL MANAGEMENT]
Procedural step. The whole procedure was performed under general
anaesthesia with TEE and ﬂuoroscopic guidance.
The mitroaortic space was 6.6mm from TEE measurement.
Implantation of 26mm SAPIEN XT valve was planned from previous
CT measurements.
The left femoral artery was punctured under angiographic guidance.
The aortic valve was crossed with Emerald straight-tip 0.035”
guidewire via 5Fr Amplatz Left 1 catheter, which was subsequently
changed to a 5Fr Pigtail catheter.
The ﬁrst balloon valvuloplasty was performed with Edwards 23mm
x 4cm Valvuloplasty balloon under rapid ventricular pacing at
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tion was seen upon inﬂation.
Repeated balloon valvuloplasty was done with the operator holding
all the delivery instruments ﬁrmly. Less but still signiﬁcant
displacement of the inﬂated balloon was observed.
The ﬁnal balloon valvuloplasty was done while the operator applied
a pushing force. This time the inﬂated balloon could hold in place but
the second operator experienced signiﬁcant resistance from the sy-
ringe plunger during balloon inﬂation. Full balloon inﬂation could not
be achieved.
Aortogram and TEE showed mild to moderate aortic regurgitation,
comparable to the pre-operative assessment.
Hemodynamically the blood pressure has improved after balloon
valvuloplasty.
TAVI was not proceeded in view of potential signiﬁcant interaction
between the pre-existing mitral prosthesis and the Edwards SAPIEN
XT heart valve.Case Summary. TAVI in patients with pre-existing mitral prosthesis
was considered an exclusion criterion in the Placement of Aortic
Transcatheter Valve (PARTNER) trial. Thus TAVI is an off-label use to
treat such a group of high risk patients.
The actual design of the mitral prosthesis and the suturing tech-
nique would affect its interaction with the transcatheter aortic bio-
prosthesis. The greater the mitroaortic space, the lower the procedure
risk.
In this case, the interference from the mitral prosthesis was so great
that it even could not acconmodate a 23mm valvuloplasty balloon at
full inﬂation. Stepping down the size of the SAPIEN XT valve to 23mm
however might result in device embolisation.
TCTAP C-226
Buying Time with Urgent Balloon Aortic Valvuloplasty While Awaiting for
TAVI in a Hemodynamic Unstable Patient with Severe Aortic Stenosis and
Very Poor Ejection Fraction
Ho-Ping Yu1
1Cheng-Hsin General Hospital, Taiwan
[CLINICAL INFORMATION]
Patient initials or identiﬁer number. A072993
Relevant clinical history and physical exam. 69-year-old lady
Chief complaint: severe dyspnea, orthopnea and cold sweating for
one day
Medical history: severe aortic stenosis, paroxysmal atrial ﬁbrillation
BP: 80/50 mmHg
CXR: acute pulmonary edema
Transthoracic echocardiography: very poor systolic function, ejec-
tion fraction of about 16%, bicuspid aortic valve with severe calciﬁ-
cation, aortic valve area of about 0.3 cm2 by continuity equation
Logistic Euroscore: 50%
